Carbapenem Based Antibiotics Market Scope And Analysis

  • Report Code : TIPRE00027228
  • Category : Life Sciences
  • Status : Published
  • No. of Pages : 180
Buy Now

Carbapenem-Based Antibiotics Market Size and Scope by 2031

Buy Now

Carbapenem-Based Antibiotics Market Report Carbapenem-Based Antibiotics Market Size and Share Carbapenem-Based Antibiotics Market Scope and Analysis

Carbapenem-Based Antibiotics Market Report Scope

Report Attribute Details
Market size in 2021 US$ 3.96 Billion
Market Size by 2028 US$ 5.35 Billion
Global CAGR (2021 - 2028) 4.4%
Historical Data 2019-2020
Forecast period 2022-2028
Segments Covered By Type
  • Meropenem
  • Doripenem
  • Imipenem
  • Tebipenem
By Indication
  • Bacterial Meningitis
  • Acute Pelvic Infections
  • Respiratory Tract Infections
  • Intra-Abdominal Infections
  • Urinary Tract Infections
By Distribution Channel
  • Retail Pharmacies
  • Online Pharmacies
  • Hospital Pharmacies
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • Pfizer Inc
  • Savior Lifetec
  • Sumitomo Dainippon Pharma Co Ltd
  • Merck Co Inc
  • Gland Pharma Limited
  • Aurobindo Pharma Ltd
  • Daewoong Pharmaceutical Co Ltd
  • Iterum Therapeutics plc
  • ACS Dobfar S p A